The Role of Hypothalamic Pathology for Non-Motor Features of Huntington’s Disease
Open Access
- 24 October 2019
- journal article
- review article
- Published by SAGE Publications in Journal of Huntington's Disease
- Vol. 8 (4) , 375-391
Abstract
Huntington’s disease (HD) is a fatal genetic neurodegenerative disorder. It has mainly been considered a movement disorder with cognitive symptoms and these features have been associated with pathology of the striatum and cerebral cortex. ImportantlKeywords
This publication has 211 references indexed in Scilit:
- Cortical Metabolites as Biomarkers in the R6/2 Model of Huntington's DiseaseJournal of Cerebral Blood Flow & Metabolism, 2011
- Reduced expression of conditioned fear in the R6/2 mouse model of Huntington's disease is related to abnormal activity in prelimbic cortexNeurobiology of Disease, 2011
- Functional identification of an aggression locus in the mouse hypothalamusNature, 2011
- Neurocognitive signs in prodromal Huntington disease.Neuropsychology, 2011
- Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysisThe Lancet Neurology, 2011
- Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysisNeurobiology of Disease, 2010
- Early atrophy of pallidum and accumbens nucleus in Huntington’s diseaseJournal of Neurology, 2010
- Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's diseaseNeurobiology of Disease, 2008
- The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse modelExperimental Neurology, 2008
- Als2 -deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalitiesProceedings of the National Academy of Sciences, 2006